CORTICO BIOSIM
Live / Allowed — First extension granted (statement of use) (as of 11 Aug 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 13 Jul 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99281137
- Mark type
- Design + words
- Filed
- 13 Jul 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- Joseph I. Hirsch
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals, namely, corticotropin compositions for use in diagnostic testing and for treatment of disorders such as endocrine disorders, nervous system diseases, rheumatic disorders, collagen diseases, dermatologic diseases, allergic states, ophthalmic diseases, respiratory diseases, hematologic disorders, neoplastic diseases, edematous state, gastrointestinal diseases, tuberculous meningitis and trichinosis
Owner
- Cortico Biosim LLC, Albuquerque, NM, US
- Cortico Biosim LLC, Albuquerque, NM, US
Prosecution history
- 12 Aug 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Aug 2026 — SOU EXTENSION 1 GRANTED
- 11 Aug 2026 — SOU EXTENSION 1 FILED
- 11 Aug 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Dec 2025 — EXAMINER'S AMENDMENT ENTERED
- 13 Dec 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 13 Dec 2025 — EXAMINERS AMENDMENT E-MAILED
- 13 Dec 2025 — EXAMINERS AMENDMENT -WRITTEN
- 02 Dec 2025 — ASSIGNED TO EXAMINER
- 19 Nov 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED